Item 2.01Item 2.01 - Completion of Acquisition
Item
2.01 Completion of Acquisition or Disposition of Assets.
The
disclosures set forth in the Introductory Note of this Current Report on Form 8-K and in Item 1.01 are incorporated into this Item 2.01
by reference.
The
Business Combination and each of the other proposals in the Proxy Statement/Prospectus were approved by FGMC’s stockholders and
by BOXABL’s stockholders at their respective meetings. As indicated above, the Combined Company issued, or reserved for issuance
an aggregate of 246,524,760 shares of Combined Company Common Stock and 103,475,240 shares of Combined Company Merger Preferred Stock
to the former stockholders of BOXABL on the Closing Date.
In
connection with the stockholder vote, an aggregate of 3,466,086 shares of FGMC Common Stock were redeemed by stockholders of FGMC
resulting in the payment to such holders of an aggregate of $36,048,176.
As
of the Closing Date and following the completion of the Business Combination, the Combined Company had approximately 241,493,343
shares of Combined Company Common Stock issued and outstanding, consisting of approximately 9,409,633 shares of Combined Company
Class A Common Stock and approximately 232,083,710 shares of Combined Company Class B Common Stock, and 103,475,240 shares
of Combined Company Merger Preferred Stock issued and outstanding. In addition, as of the Closing Date, the Combined Company had 1,000,000
Combined Company Warrants issued and outstanding, each entitling the holder thereof to purchase one share of Combined Company Common
Stock at an exercise price of $15.00 per share.
FORM
10 INFORMATION
Item
2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as FGMC was immediately before the consummation of
the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general
form for registration of securities on Form 10. Accordingly, the Combined Company is providing below the information that would be included
in the Form 10 if it were to file a Form 10. Please note that the information provided below relates to the Combined Company following
the consummation of the Business Combination, unless otherwise specifically indicated or the context otherwise requires.
Cautionary
Note Regarding Forward-Looking Statements
This
document and the information incorporated by reference herein include “forward-looking statements” within the meaning of
the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements
of present or historical fact included in or incorporated by reference in this Current Report on Form 8-K, regarding the Combined Company’s
future financial performance, as well as its strategy, future operations, financial position, estimated revenues and losses, projected
costs, prospects, plans and objectives of management are forward-looking statements. When used in this Current Report on Form 8-K, the
words “could,” “should,” “will,” “may,” “believe,” “anticipate,”
“intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar
expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying
words. These forward-looking statements are based on management’s current expectations and assumptions about future events and
are based on currently available information as to the outcome and timing of future events. The Combined Company cautions you that these
forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which
are beyond the control of the Combined Company, incident to its business.
These
forward-looking statements are based on information available as of the date of this Current Report on Form 8-K, and current expectations,
forecasts and assumptions, and involve a number of risks and uncertainties. Accordingly, forward-looking statements should not be relied
upon as representing the Combined Company’s views as of any subsequent date, and the Combined Company does not undertake any obligation
to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information,
future events or otherwise, except as may be required under applicable securities laws.
As
a result of a number of known and unknown risks and uncertainties, the Combined Company’s actual results or performance may be
materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results
to differ include:
the
Combined Company’s limited operating history and history of losses, including the going
concern qualification in BOXABL’s audited financial statements;
the
Combined Company’s ability to recognize the anticipated benefits of the Business Combination,
which may be affected by, among other things, competition and the ability of the Combined
Company to grow and manage growth profitably following the Closing Date;
future
capital needs and the ability to obtain additional financing on acceptable terms;
the
ability to maintain the listing of the Combined Company Class A Common Stock on Nasdaq following
the Closing Date;
the
ability to successfully ramp production capacity and reduce per-unit production costs;
risks
relating to regulatory approvals for modular housing in additional states and jurisdictions;
demand
cyclicality and housing market conditions;
supply
chain disruptions, including reliance on key suppliers and the risk of supplier failure;
reliance
on senior management, including Paolo Tiramani and Galiano Tiramani;
intellectual
property protection and potential infringement claims;
reliance
on third-party builders, dealers, installers and franchisees;
competition
from traditional and modular construction companies;
increased
costs associated with being a public company;
potential
dilution from conversion of Merger Preferred Stock and other securities;
conflicts
of interest involving management and directors;
controlled
company status under Nasdaq rules;
no
third-party fairness opinion obtained in connection with the Business Combination;
no
minimum cash closing condition in the Merger Agreement; and
other
risks and uncertainties set forth in the Proxy Statement/Prospectus in the section titled
“Risk Factors.”
Business
and Facilities
The
information set forth in the section of the Proxy Statement/Prospectus entitled “ Information About BOXABL ” beginning
on page 244 is incorporated herein by reference.
Risk
Factors
The
risks associated with the Combined Company’s business and operations following the Closing Date are described in the Proxy Statement/Prospectus
in the section entitled “ Risk Factors ” beginning on page 65, which is incorporated herein by reference.
Financial
Information
Audited
Financial Statements
The
following historical audited financial statements and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus
and filed as exhibits hereto:
Audited
financial statements of FGMC as of and for the years ended December 31, 2025 and December
31, 2024, audited by Fruci & Associates II, PLLC.
Audited
financial statements of BOXABL as of and for the year ended December 31, 2025, audited by
CBIZ CPAs P.C.
Audited
financial statements of BOXABL as of and for the year ended December 31, 2024, audited by
Marcum LLP.
─────────────────────────────────────────────────────────────────────────────────────────────
The
historical financial statements of FGMC and BOXABL and the related notes are included as Exhibits 99.1 and 99.2 to this Current Report
on Form 8-K and incorporated by reference herein.
Unaudited Interim Financial
Statements
The unaudited interim consolidated
financial statements of BOXABL as of and for the three months ended March 31, 2026 and March 31, 2025, including the consolidated balance
sheet, consolidated statements of comprehensive loss, consolidated statements of cash flows, and related notes, are included as Exhibit
99.5 to this Current Report on Form 8-K and incorporated by reference herein. The unaudited interim financial statements of FGMC as of and for the three months ended March 31, 2026, and March
31, 2025, including the balance sheet, statements of operations, statements of cash flows, and related notes, are included as Exhibit
99.7 to this Current Report on Form 8-K and incorporated by reference herein.
Unaudited
Pro Forma Condensed Combined Financial Information
The
unaudited pro forma condensed combined financial
information of FGMC and BOXABL as of March 31, 2026, for the three months ended March 31, 2026, and for the
year ended December 31, 2025 is set forth in Exhibit 99.3 hereto and incorporated by reference herein.
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
Management’s
discussion and analysis of the financial condition and results of operations of BOXABL prior to the Closing Date is included in the Proxy
Statement/Prospectus, which is incorporated herein by reference.
Management’s
Discussion and Analysis of Financial Condition and Results of Operations of BOXABL for the year ended December 31, 2025 is included
as Exhibit 99.4 to this Current Report on Form 8-K and incorporated by reference herein. Management’s
Discussion and Analysis of Financial Condition and Results of Operations of BOXABL for the three months ended March 31, 2026,
compared to the three months ended March 31, 2025, is included as Exhibit 99.6 to this Current Report on Form 8-K and incorporated
by reference herein. Management’s Discussion and Analysis of Financial Condition and Results of Operations of FGMC for the three
months ended March 31, 2026, compared to the three months ended March 31, 2025, is included as Exhibit 99.8 to this Current Report on
Form 8-K and incorporated by reference herein.
Security
Ownership of Certain Beneficial Owners and Management
The
following table sets forth information regarding the beneficial ownership of the Combined Company common stock as of the Closing Date
by:
each
person who is known to be the beneficial owner of more than 5% of the Combined Company common
stock;
each
executive officer and director of the Combined Company; and
all
executive officers and directors of the Combined Company as a group.
Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security
if he, she or it possesses sole or shared voting or investment power over that security, including options, rights and convertible securities
that are currently exercisable or exercisable within 60 days.
The
beneficial ownership of Combined Company Common Stock is based on 241,493,343 shares of Combined Company Common Stock issued and
outstanding immediately following the Closing Date.
Name of Beneficial Owner(1) Number of Shares % of Common Stock
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Directors and Executive Officers
Paolo Tiramani(3) 172,470,048 (2) 71.42%
Galiano Tiramani(4) 60,052,681 (2) 24.87%
Martin Noe Costas — —
Morris A. Davis — —
Zvi Yemini — —
Larry G. Swets, Jr. 200,000 *
All executive officers and directors as a group (6 persons) 232,722,729 96.37%
(1)
Unless otherwise noted, the business address of each of the following entities and individuals is 5345 E. N. Belt Road, North Las Vegas,
Nevada 89115.
(2) Represents
shares of Combined Company Class B Common Stock, par value $0.0001 per share. Each share of Class B Common Stock is entitled to ten (10)
votes per share on all matters on which stockholders are generally entitled to vote. Holders of Class A Common Stock and Class B Common
Stock vote together as a single class on all matters submitted to a vote of stockholders. Each share of Class B Common Stock is convertible
into one (1) fully paid and nonassessable share of Class A Common Stock at the option of the holder at any time. Shares of Class B Common
Stock may be issued only to, and registered in the name of, Paolo Tiramani, Galiano Tiramani and their respective permitted transferees.
Immediately prior to any transfer of shares of Class B Common Stock to a person other than a permitted transferee, each share of Class
B Common Stock so transferred shall automatically convert into one (1) share of Class A Common Stock.
(3) Includes
838,101 shares held directly, 84,767,646 shares held by the Paolo Tiramani 2020 Family Gift Trust, and 86,864,301 shares held by the
Austin Powers Trust, each of which are shares of Combined Company Class B Common Stock.
(4) Includes
389,629 shares held directly, 30,998,869 shares held by the Galiano Tiramani 2020 Family Gift Trust, and 28,225,164 shares held by the
Shontor Asset Protection Trust, each of which are shares of Combined Company Class B Common Stock. Also includes 439,019 shares issuable upon the exercise or vesting of outstanding
options or other rights to acquire Combined Company Common Stock held by Mr. Tiramani’s spouse that are exercisable within 60 days.
Information
about Directors and Executive Officers
Name Age Position
Held
───────────────────────────────────────────────────────────────────────────
Paolo 66 Co-Chief
Tiramani Executive Officer and Chairman of the Board
Galiano 38 Co-Chief
Tiramani Executive Officer and Director
Martin 49 Chief
Noe Costas Financial Officer and Treasurer
Morris 54 Director
A. Davis
Zvi 75 Director
Yemini
Larry 51 Director
G. Swets, Jr.
Resignations
and Appointments
In
connection with the closing of the Business Combination, any pre-existing officers and directors of FGMC resigned from their respective
positions as officers and/or directors of FGMC, in each case effective as of the Effective Time on the Closing Date. Effective as of
the Closing Date, Paolo Tiramani was appointed as Co-Chief Executive Officer and Chairman of the Board, Galiano Tiramani was appointed
as Co-Chief Executive Officer and a director, Martin Noe Costas was appointed as Chief Financial Officer and Treasurer, and each of Morris
A. Davis, Zvi Yemini and Larry G. Swets, Jr. was appointed as a director of the Combined Company.
Information
with respect to Combined Company’s directors and officers appointed as of the Closing Date, including biographical information
regarding these individuals, is set forth in the Proxy Statement/Prospectus in the section entitled “Management of Combined Company
Following the Business Combination” beginning on page 275, which information is incorporated herein by reference.
Risk
Oversight
The
Board of Directors of the Combined Company (the “ Board ”) has extensive involvement in the oversight of risk management
related to the Combined Company and its business and accomplishes this oversight through regular reporting to the Board by the audit
committee. The audit committee represents the Board by periodically reviewing the Combined Company’s accounting, reporting and
financial practices, including the integrity of its financial statements, the surveillance of administrative and financial controls and
its compliance with legal and regulatory requirements.
Director
Independence
The
Board consists of five members. Other than Paolo Tiramani and Galiano Tiramani, the director nominees (Morris A. Davis, Larry G. Swets,
Jr. and Zvi Yemini) are expected to qualify as “independent directors” as defined under the listing requirements and rules
of Nasdaq and the applicable rules of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”). The Combined
Company may be deemed a “controlled company” under Nasdaq rules because its executive officers are expected to hold more
than 50% of the combined voting power of the Combined Company’s outstanding voting securities.
Committees
of the Board of Directors
Audit
Committee
The
Combined Company’s audit committee is responsible for, among other things:
●
selecting, retaining, compensating, overseeing and, if necessary, terminating the Combined Company’s independent registered public
accounting firm, subject to any stockholder ratification of the selection of the independent auditors;
●
pre-approving all audit and permitted non-audit and tax services to be provided by the Combined Company’s independent registered
public accounting firm or other registered public accounting firms, and establishing policies and procedures for such pre-approval on
an ongoing basis;
●
reviewing and discussing with the Combined Company’s independent registered public accounting firm the firm’s internal quality
control procedures, any material issues raised by internal quality control reviews, peer reviews, PCAOB inspections or governmental or
professional inquiries, and all relationships between the firm and the Combined Company or its subsidiaries that may bear on the firm’s
objectivity and independence;
●
evaluating, at least annually, the qualifications, performance and independence of the Combined Company’s independent registered
public accounting firm, including the lead audit partner, and overseeing required lead audit partner rotation;
●
reviewing and discussing with the Combined Company’s independent registered public accounting firm the auditors’ responsibilities,
the overall audit strategy, the scope and timing of the annual audit, significant risks identified during the audit, significant audit
findings, critical accounting policies and practices, alternative GAAP treatments discussed with management, and other material written
communications between the auditors and management;
●
reviewing and discussing with the Combined Company’s independent registered public accounting firm and management any audit problems
or difficulties, significant disagreements with management and management’s response, and resolving any disagreements between the
auditors and management;
●
reviewing with management and the Combined Company’s independent registered public accounting firm major issues regarding accounting
principles and financial statement presentation, significant financial reporting judgments, the effect of regulatory and accounting initiatives
and off-balance sheet structures, and the adequacy and effectiveness of the Combined Company’s financial reporting processes, internal
control over financial reporting and disclosure controls and procedures;
●
reviewing and discussing with management and the Combined Company’s independent registered public accounting firm the Combined
Company’s annual and quarterly financial statements, related MD&A disclosure, required certifications, audit opinions, and
disclosures relating to financial reporting processes and internal controls before the Combined Company’s Form 10-K and Form 10-Q
filings are made with the SEC;
●
recommending to the Board whether the audited financial statements and related MD&A disclosure should be included in the Combined
Company’s Annual Report on Form 10-K and producing the audit committee report required to be included in the Combined Company’s
proxy statement;
●
reviewing and discussing with management and the Combined Company’s independent registered public accounting firm the Combined
Company’s earnings releases, if any, including the presentation of financial information, use of pro forma, adjusted or other non-GAAP
financial information, and financial information or earnings guidance provided to analysts and ratings agencies;
●
establishing and overseeing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting
controls or auditing matters and for the confidential, anonymous submission by employees of concerns regarding questionable accounting
or auditing matters;
●
reviewing and discussing with management the risks faced by the Combined Company and the policies, guidelines and processes by which
management assesses and manages such risks, including major financial risk exposures and risks relating to permitting and licensing,
environmental matters, cybersecurity, third-party liability, supply chain issues, litigation and personnel oversight;
●
reviewing the Combined Company’s compliance with applicable laws and regulations and overseeing policies, procedures and programs
designed to promote legal, ethical and regulatory compliance, including monitoring compliance with Combined Company’s code of ethics;
●
reviewing, with the General Counsel and outside legal counsel, legal and regulatory matters, including legal proceedings and regulatory
investigations, that could have a significant impact on the Combined Company’s financial statements;
●
reviewing, approving and overseeing transactions between the Combined Company and related persons, as defined in Item 404 of Regulation
S-K, and other potential conflict of interest situations, and developing policies and procedures for approval of related-party transactions;
and
●
retaining independent outside counsel and other advisors as the audit committee deems necessary, with authority to determine compensation
and oversee the work of such advisors.
The
Combined Company’s audit committee consists of Morris A. Davis, Larry G. Swets, Jr. and Zvi Yemini, with Morris A. Davis serving
as Chairperson. The Board has determined that Morris A. Davis qualifies as an “audit committee financial expert” as such
term is defined in Item 407(d)(5) of Regulation S-K. Each member of the audit committee meets the definition of “independent director”
for purposes of serving on the audit committee under the Nasdaq rules and the independence standards under Rule 10A-3 of the Exchange
Act.
Compensation
Committee
The
Combined Company’s compensation committee is responsible for, among other things:
●
reviewing and approving annually the corporate goals and objectives applicable to the compensation of the Combined Company’s Chief
Executive Officer;
●
evaluating at least annually the Chief Executive Officer’s performance in light of such goals and objectives and determining and
approving the Chief Executive Officer’s compensation based on such evaluation, with the Chief Executive Officer not present during
any deliberations or voting regarding his or her compensation;
●
reviewing and approving the compensation of the Combined Company’s other executive officers;
●
reviewing, approving and, when appropriate, recommending to the Board for approval, incentive compensation plans and equity-based plans,
including the adoption, amendment and termination of such plans and, where appropriate or required, recommending such plans for stockholder
approval;
●
administering the Combined Company’s incentive compensation plans and equity-based plans, including designating eligible employees
to receive awards, determining the amount of awards or equity to be granted and approving the terms and conditions applicable to each
award or grant, subject to the terms of the applicable plan;
●
reviewing and discussing with management the Combined Company’s executive compensation information and, when required by SEC rules,
the Compensation Discussion and Analysis, and recommending that such disclosure be included in the Combined Company’s annual report
on Form 10-K and proxy statement;
●
producing the compensation committee report on executive officer compensation required to be included in the Combined Company’s
proxy statement or annual report on Form 10-K;
●
reviewing, approving and, when appropriate, recommending to the Board for approval, any employment agreements and severance arrangements
or plans, including benefits to be provided in connection with a change in control, for the Chief Executive Officer and other executive
officers;
●
reviewing, approving and, when appropriate, recommending to the Board for approval, employee benefit plans, including the adoption, amendment
and termination of such plans, and exercising fiduciary and administrative authority with respect to such plans to the extent delegated
to the committee;
●
reviewing the Combined Company’s incentive compensation arrangements to determine whether they encourage excessive risk-taking,
reviewing and discussing at least annually the relationship between risk management policies and practices and compensation, and evaluating
compensation policies and practices that could mitigate any such risk;
●
once required by SEC rules, reviewing and recommending to the Board the frequency of stockholder advisory votes on executive compensation
and reviewing and approving the related proxy statement proposals;
●
reviewing all director compensation and benefits for service on the Board and Board committees at least annually and recommending any
changes to the Board as necessary;
●
overseeing, in conjunction with the nominating and corporate governance committee, engagement with stockholders and proxy advisory firms
on executive compensation matters; and
●
selecting, retaining and obtaining advice from compensation consultants, outside legal counsel and other advisors as the committee deems
necessary, including determining their compensation, overseeing their work and assessing their independence as required under applicable
SEC and Nasdaq rules.
The
Combined Company’s compensation committee consists of Morris A. Davis, Larry G. Swets, Jr. and Zvi Yemini, with Morris A. Davis
serving as Chairperson. Each member of the compensation committee meets the definition of “independent director” under the
Nasdaq rules.
Nominating
and Corporate Governance Committee
The
Combined Company’s nominating and corporate governance committee is responsible for, among other things:
●
determining the qualifications, qualities, skills and other expertise required to serve as a director and developing and recommending
to the Board criteria to be considered in selecting director nominees;
●
identifying and screening individuals qualified to become members of the Board, consistent with the director criteria approved by the
Board;
●
making recommendations to the Board regarding the selection and approval of director nominees to be submitted to a stockholder vote at
the annual meeting of stockholders;
●
considering director nominations validly made by stockholders in accordance with applicable laws, rules and regulations and the Combined
Company’s charter documents;
●
developing and recommending to the Board corporate governance guidelines applicable to the Combined Company, reviewing those guidelines
at least annually and recommending any changes to the Board;
●
overseeing the Combined Company’s corporate governance policies, practices and procedures, including identifying best practices
and reviewing and recommending to the Board changes to the Combined Company’s corporate governance framework, including its certificate
of formation, bylaws and any stockholder agreement then in effect;
●
developing, subject to Board approval, a process for the annual evaluation of the Board and its committees and overseeing the conduct
of such annual evaluation;
●
reviewing the Board’s committee structure and composition and making annual recommendations to the Board regarding the appointment
of directors to serve as members and chairpersons of each committee;
●
identifying and making recommendations to the Board regarding candidates to fill vacancies on the Board or any Board committee, whether
by stockholder election or appointment by the Board;
●
developing and overseeing an orientation program for new directors and a continuing education program for current directors, and periodically
reviewing and updating those programs as necessary;
●
reviewing all director compensation and benefits for service on the Board and Board committees at least annually and recommending any
changes to the Board as necessary;
●
reviewing related-party transactions, as defined by Item 404 of Regulation S-K, and conflicts of interest identified by the audit committee
for compliance with applicable independence standards in connection with committee service or the nomination of an individual to serve
on the Board or a Board committee;
●
reviewing and discussing with management disclosure regarding the Combined Company’s corporate governance practices, including
disclosure concerning the operations of the committee and other Board committees, director independence and the director nominations
process, and recommending that such disclosure be included in the Combined Company’s proxy statement or annual report on Form 10-K,
as applicable;
●
reviewing the Combined Company’s code of ethics and periodically recommending any changes to the code to the Board;
●
reviewing any director resignation letter tendered and evaluating and recommending to the Board whether such resignation should be accepted;
●
overseeing the Combined Company’s practices and strategy relating to workforce health and safety, human capital management, energy
efficiency and the environmental impact of the Combined Company’s homebuilding process, home affordability, business ethics and
compliance, and data privacy and protection; and
●
selecting, retaining and obtaining advice from director search firms, outside counsel, executive search firms and other advisors as the
committee deems necessary, including determining their compensation, overseeing their work and assessing their independence as appropriate.
The
Combined Company’s nominating and corporate governance committee consists of Morris A. Davis, Larry G. Swets, Jr. and Zvi Yemini,
with Zvi Yemini serving as Chairperson.
Code
of Business Conduct and Ethics
The
Combined Company has adopted a written code of business conduct and ethics that applies to its directors, officers and employees, including
its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar
functions. A copy of the code is posted on the Combined Company’s website at https://www.boxabl.com/ir. In addition, the Combined
Company intends to post on its website all disclosures that are required by law or the Nasdaq rules concerning any amendments to, or
waivers from, any provision of the code. The information on the Combined Company’s website is deemed not to be incorporated in
this Current Report on Form 8-K.
Executive
Compensation
The
Combined Company’s named executive officers are Paolo Tiramani (Co-Chief Executive Officer), Galiano Tiramani (Co-Chief Executive
Officer) and Martin Noe Costas (Chief Financial Officer and Treasurer).
The
Combined Company does not have employment agreements
with its named executive officers and has not maintained any pension, retirement or similar benefit plans for its named executive officers.
The Combined Company intends to evaluate its executive compensation philosophy and plans following the consummation of the Business Combination.
The
information regarding executive compensation of the Combined Company’s named executive officers is set forth in the Proxy
Statement/Prospectus in the section entitled “Executive Officer and Director Compensation” beginning on page 282 of the Proxy
Statement/Prospectus, which is incorporated herein by reference.
Overview
of Anticipated Executive Compensation Program
Following
the Closing Date, decisions with respect to the compensation of the Combined Company’s executive officers, including its named
executive officers, will be made by the compensation committee of the Board. The Combined Company anticipates that compensation for its
executive officers will have the following components: base salary, cash bonus opportunities, equity compensation, employee benefits
and severance protections. The Combined Company will use annual cash bonuses and equity awards to promote performance-based pay that
aligns the interests of its executive officers with the long-term interests of its stockholders and enhances executive retention.
Certain
Relationships and Related Transactions
Certain
relationships and related-party transactions are described in the Proxy Statement/Prospectus in the section titled “Certain Relationships
and Related Person Transactions” beginning on page 291 of the Proxy Statement/Prospectus, which is incorporated herein by reference.
Legal
Proceedings
From
time to time, the Combined Company and its subsidiaries may become involved in legal proceedings arising in the ordinary course of its
business. BOXABL has initiated legal proceedings against a key supplier that failed to deliver deposits and custom equipment, seeking
damages, specific performance and other remedies. That matter remains pending. BOXABL does not anticipate additional material adverse
impacts on its financial condition from such proceedings.
A
Securities and Exchange Commission investigation involving a former BOXABL employee’s fraudulent securities activities concluded
by July 2024 without SEC enforcement action against BOXABL.
For additional information regarding
legal proceedings involving the Combined Company and its subsidiaries, see “Item 3. Legal Proceedings” in BOXABL’s
Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 27, 2026 (Commission File No. 000-56579),
and “Part II, Item 1. Legal Proceedings” in BOXABL’s Quarterly Report on Form 10-Q for the quarterly period ended March
31, 2026, filed with the SEC on May 15, 2026 (Commission File No. 000-56579), the disclosures of which are incorporated herein by reference.
Market
Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters
Market
Information and Holders
Immediately
prior to the closing of the Business Combination, the FGMC Units, FGMC Common Stock and FGMC Rights were listed on Nasdaq under the symbols
“FGMCU,” “FGMC” and “FGMCR,” respectively.
As
of the Closing Date, FGMC’s Units separated into their component securities. As a result, the FGMC Units and FGMC Rights no longer
trade.
On
the Closing Date, the Combined Company Class A Common Stock was listed on Nasdaq under the new trading symbol “BXBL.” The
Combined Company Merger Preferred Stock is not listed on Nasdaq or any other securities exchange and is not publicly traded. The Combined
Company Class B Common Stock is not listed and is not publicly traded.
As
of the Closing Date and following the completion of the Business Combination, the Combined Company had approximately 241,493,343
shares of common stock issued and outstanding held of record by 4,528 holders. Such numbers do not include Depository Trust Company
participants or beneficial owners holding shares through nominee names.
Dividends
The
Combined Company has not paid any cash dividends on its common stock to date. The Combined Company may retain future earnings, if any,
for future operations, expansion and debt repayment and has no current plans to pay cash dividends for the foreseeable future. Any decision
to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, the Combined
Company’s results of operations, financial condition, cash requirements, contractual restrictions and other factors that the Board
may deem relevant. The Combined Company does not anticipate declaring any cash dividends to holders of common stock in the foreseeable
future.
Recent
Sales of Unregistered Securities
The
information provided in the Introductory Note and Item 1.01 of this Form 8-K is incorporated by reference into this section.
Description
of Registrant’s Securities
The
description of the Combined Company’s securities is set forth in the section of the Proxy Statement/Prospectus entitled “ Description
of the Combined Company’s Securities ” beginning on page 293 of the Proxy Statement/Prospectus, which information is incorporated
herein by reference.
Indemnification
of Directors and Officers
The
TBOC authorizes corporations to limit or eliminate, subject to certain conditions, the personal liability of directors and officers to
corporations and their stockholders for monetary damages for breach of their fiduciary duties. The Combined Company’s organizational
documents limit the liability of its directors and officers to the fullest extent permitted by Texas law.
The
Combined Company expects to purchase director and officer liability insurance to cover liabilities its directors and officers may incur
in connection with their services to the Combined Company, including matters arising under the Securities Act. The Combined Company’s
organizational documents also provide that the Combined Company will indemnify its directors and officers to the fullest extent permitted
by Texas law. In addition, the Combined Company intends to enter into customary indemnification agreements with each of its officers
and directors, as described above in Item 1.01.
There
is no pending litigation or proceeding involving any of the Combined Company’s directors, officers, employees or agents in which
indemnification will be required or permitted. The Combined Company is not aware of any threatened litigation or proceedings that may
result in a claim for such indemnification.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling
the Combined Company, the Combined Company has been informed that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable.
Financial
Statements and Supplementary Data
The
information set forth under Item 9.01 of this Current Report on Form 8-K is incorporated herein by reference.